Holoxan 1 g powder for solution for infusion
Country: Bulgarija
Lingwa: Bulgaru
Sors: Изпълнителна агенция по лекарствата
Fuljett ta 'informazzjoni
(PIL)
15-05-2023
Karatteristiċi tal-prodott
(SPC)
15-05-2023
Ingredjent attiv:
Ифосфамид
Disponibbli minn:
Baxter Oncology GmbH.
Kodiċi ATC:
L01AA6
INN (Isem Internazzjonali):
Ifosfamide
Dożaġġ:
1 g powder for solution for infusion
Sommarju tal-prodott:
Holoxan, 1g powder for solution for infusion x 1;
Data ta 'l-awtorizzazzjoni:
2014-11-03
